1. EPR investigations of the iron domain in neuromelanin;Aime;Biochem. Biophys. Acta,1997
2. Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson’s disease;Aime;Mov. Disord.,2000
3. Aime S, Fasano M, Bergamasco B, Lopiano L, Quattrocolo G. Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. In: Battistini L, Scarlato G, Caraceni T, Ruggieri S, editors. Advances in neurology. Philadelphia: Lippencott-Raven Publishers; 1996. p. 263–70.
4. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer’s and Huntington’s disease;Bartzokis;Cell Mol. Biol. (Noisy-le-Grand),2000
5. Iron–melanin interaction and lipid peroxidation: implications for Parkinson’s disease;Ben-Shachar;J. Neurochem.,1991